Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Infant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in utero.

Marsit CJ, Brummel SS, Kacanek D, Seage GR 3rd, Spector SA, Armstrong DA, Lester BM, Rich K; Pediatric HIV/AIDS Cohort Studies Network.

Epigenetics. 2015;10(8):708-16. doi: 10.1080/15592294.2015.1060389.

2.

Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.

Nozyce ML, Huo Y, Williams PL, Kapetanovic S, Hazra R, Nichols S, Hunter S, Smith R, Seage GR 3rd, Sirois PA; Pediatric HIVAIDS Cohort Study.

Pediatr Infect Dis J. 2014 Nov;33(11):1128-33. doi: 10.1097/INF.0000000000000410.

3.

Foetal loss and enhanced fertility observed in mice treated with Zidovudine or Nevirapine.

Onwuamah CK, Ezechi OC, Herbertson EC, Audu RA, Ujah IA, Odeigah PG.

PLoS One. 2014 Sep 18;9(9):e107899. doi: 10.1371/journal.pone.0107899. eCollection 2014.

4.

Exposure of Allium cepa root cells to zidovudine or nevirapine induces cytogenotoxic changes.

Onwuamah CK, Ekama SO, Audu RA, Ezechi OC, Poirier MC, Odeigah PG.

PLoS One. 2014 Mar 5;9(3):e90296. doi: 10.1371/journal.pone.0090296. eCollection 2014.

5.

Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants.

Jao J, Abrams EJ.

Pediatr Infect Dis J. 2014 Jul;33(7):734-40. doi: 10.1097/INF.0000000000000224. Review.

6.

Motor development of infants exposed to maternal human immunodeficiency virus (HIV) but not infected.

Herrero D, Gallo PR, Fujimori M, de Mello Monteiro CB, Valenti VE, Tavares CM, Gallo SM, Macedo CC, Oliveira AG, de Abreu LC.

Int Arch Med. 2013 Oct 31;6(1):45. doi: 10.1186/1755-7682-6-45.

7.

Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025.

Read JS, Huo Y, Patel K, Mitchell M, Scott GB.

J Pediatric Infect Dis Soc. 2012 Jun;1(2):92-102. doi: 10.1093/jpids/pis036. Epub 2012 May 3.

8.

Case treated with triple therapy of lamivudine, interferon-β and prednisolone for acute exacerbation of chronic hepatitis B during pregnancy.

Koh M, Shinohara J, Hongo Y, Okazaki T, Takitani K, Tamai H.

Hepatol Res. 2013 Apr;43(4):425-9. doi: 10.1111/j.1872-034X.2012.01077.x.

9.

Growth and body composition of uninfected children exposed to human immunodeficiency virus: comparison with a contemporary cohort and United States National Standards.

Neri D, Somarriba GA, Schaefer NN, Chaparro AI, Scott GB, Lopez Mitnik G, Ludwig DA, Miller TL.

J Pediatr. 2013 Jul;163(1):249-54.e1-2. doi: 10.1016/j.jpeds.2012.12.034. Epub 2013 Jan 26.

10.

Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.

Sirois PA, Huo Y, Williams PL, Malee K, Garvie PA, Kammerer B, Rich K, Van Dyke RB, Nozyce ML; Pediatric HIVAIDS Cohort Study.

Pediatr Infect Dis J. 2013 Jun;32(6):648-55. doi: 10.1097/INF.0b013e318284129a.

11.

Antiretrovirals and safer conception for HIV-serodiscordant couples.

Matthews LT, Smit JA, Cu-Uvin S, Cohan D.

Curr Opin HIV AIDS. 2012 Nov;7(6):569-78. doi: 10.1097/COH.0b013e328358bac9. Review. Erratum in: Curr Opin HIV AIDS. 2013 Jan;8(1):86.

12.

Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.

Crain MJ, Williams PL, Griner R, Tassiopoulos K, Read JS, Mofenson LM, Rich KC; Pediatric HIVAIDS Cohort Study.

Pediatr Infect Dis J. 2011 Dec;30(12):1069-74. doi: 10.1097/INF.0b013e318234c886.

13.

Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).

Lipshultz SE, Shearer WT, Thompson B, Rich KC, Cheng I, Orav EJ, Kumar S, Pignatelli RH, Bezold LI, LaRussa P, Starc TJ, Glickstein JS, O'Brien S, Cooper ER, Wilkinson JD, Miller TL, Colan SD.

J Am Coll Cardiol. 2011 Jan 4;57(1):76-85. doi: 10.1016/j.jacc.2010.08.620.

14.

Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication.

Watts DH, Huang S, Culnane M, Kaiser KA, Scheuerle A, Mofenson L, Stanley K, Newell ML, Mandelbrot L, Delfraissy JF, Cunningham CK.

J Perinat Med. 2011 Mar;39(2):163-70. doi: 10.1515/JPM.2010.139. Epub 2010 Dec 13.

15.

Effects of gender on the health and development of medically at-risk infants.

Cho J, Holditch-Davis D, Miles MS.

J Obstet Gynecol Neonatal Nurs. 2010 Sep-Oct;39(5):536-49. doi: 10.1111/j.1552-6909.2010.01171.x.

16.

Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs).

Divi RL, Einem TL, Fletcher SL, Shockley ME, Kuo MM, St Claire MC, Cook A, Nagashima K, Harbaugh SW, Harbaugh JW, Poirier MC.

Toxicol Sci. 2010 Nov;118(1):191-201. doi: 10.1093/toxsci/kfq235. Epub 2010 Aug 11.

17.

Care of the infant born to an HIV-positive mother.

[No authors listed]

Paediatr Child Health. 2000 Apr;5(3):161-70. English, French. No abstract available.

18.

Testing for human immunodeficiency virus type 1 (HIV-1) infection in pregnancy.

[No authors listed]

Paediatr Child Health. 2001 Nov;6(9):685-97. English, French. No abstract available.

19.

Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM; PACTG 219C Team.

Pediatrics. 2010 Feb;125(2):e250-60. doi: 10.1542/peds.2009-1112. Epub 2010 Jan 18.

20.

Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.

Aldrovandi GM, Chu C, Shearer WT, Li D, Walter J, Thompson B, McIntosh K, Foca M, Meyer WA 3rd, Ha BF, Rich KC, Moye J Jr.

Pediatrics. 2009 Dec;124(6):e1189-97. doi: 10.1542/peds.2008-2771. Epub 2009 Nov 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk